Literature DB >> 16603549

Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells.

Zhanglin Ni1, Nicole M Okeley, Brian P Smart, Michael H Gelb.   

Abstract

Gastric epithelial cells liberate prostaglandin E(2) in response to cytokines as part of the process of healing of gastric lesions. Treatment of the rat gastric epithelial cell line RGM1 with transforming growth factor-alpha and interleukin-1beta leads to synergistic release of arachidonate and production of prostaglandin E(2). Results with highly specific and potent phospholipase A(2) inhibitors and with small interfering RNA show that cytosolic phospholipase A(2)-alpha and group IIA secreted phospholipase A(2) contribute to arachidonate release from cytokine-stimulated RGM1 cells. In the late phase of arachidonate release, group IIA secreted phospholipase A(2) is induced (detected at the mRNA and protein levels), and the action of cytosolic phospholipase A(2)-alpha is required for this induction. Results with RGM1 cells and group IIA secreted phospholipase A(2)-transfected HEK293 cells show that the group IIA phospholipase acts prior to externalization from the cells. RGM1 cells also express group XIIA secreted phospholipase A(2), but this enzyme is not regulated by cytokines nor does it contribute to arachidonate release. The other eight secreted phospholipases A(2) were not detected in RGM1 cells at the mRNA level. These results clearly show that cytosolic and group IIA secreted phospholipases A(2) work together to liberate arachidonate from RGM1 cell phospholipids in response to cytokines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603549      PMCID: PMC2405944          DOI: 10.1074/jbc.M513874200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Pyrrolidine inhibitors of human cytosolic phospholipase A2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone'.

Authors:  K Seno; T Okuno; K Nishi; Y Murakami; K Yamada; S Nakamoto; T Ono
Journal:  Bioorg Med Chem Lett       Date:  2001-02-26       Impact factor: 2.823

2.  Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2.

Authors:  Makoto Murakami; Kumiko Yoshihara; Satoko Shimbara; Gerald Lambeau; Michael H Gelb; Alan G Singer; Masatsugu Sawada; Naoki Inagaki; Hiroichi Nagai; Motoko Ishihara; Yukio Ishikawa; Toshiharu Ishii; Ichiro Kudo
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

3.  Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells.

Authors:  S Akiba; R Hatazawa; K Ono; K Kitatani; M Hayama; T Sato
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

4.  Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells.

Authors:  S Bezzine; R S Koduri; E Valentin; M Murakami; I Kudo; F Ghomashchi; M Sadilek; G Lambeau; M H Gelb
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

5.  A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

Authors:  John D Bradley; Alexei A Dmitrienko; Alan J Kivitz; Oscar S Gluck; Arthur L Weaver; Craig Wiesenhutter; Stephen L Myers; Gregory D Sides
Journal:  J Rheumatol       Date:  2005-03       Impact factor: 4.666

6.  On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes.

Authors:  E Valentin; F Ghomashchi; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

7.  Transforming growth factor-alpha stimulates prostaglandin generation through cytosolic phospholipase A(2) under the control of p11 in rat gastric epithelial cells.

Authors:  S Akiba; R Hatazawa; K Ono; M Hayama; H Matsui; T Sato
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

Review 8.  The expanding superfamily of phospholipase A(2) enzymes: classification and characterization.

Authors:  D A Six; E A Dennis
Journal:  Biochim Biophys Acta       Date:  2000-10-31

Review 9.  Roles of secretory phospholipases A(2) in inflammatory diseases and trauma.

Authors:  T J Nevalainen; M M Haapamäki; J M Grönroos
Journal:  Biochim Biophys Acta       Date:  2000-10-31

10.  Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.

Authors:  Hiroshi Kuwata; Takuya Nonaka; Makoto Murakami; Ichiro Kudo
Journal:  J Biol Chem       Date:  2005-05-06       Impact factor: 5.157

View more
  26 in total

Review 1.  Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis.

Authors:  William L Smith; Yoshihiro Urade; Per-Johan Jakobsson
Journal:  Chem Rev       Date:  2011-09-27       Impact factor: 60.622

2.  Golgi-associated cPLA2alpha regulates endothelial cell-cell junction integrity by controlling the trafficking of transmembrane junction proteins.

Authors:  Elsa Regan-Klapisz; Vincent Krouwer; Miriam Langelaar-Makkinje; Laxman Nallan; Michael Gelb; Hans Gerritsen; Arie J Verkleij; Jan Andries Post
Journal:  Mol Biol Cell       Date:  2009-08-12       Impact factor: 4.138

3.  NGF induces the expression of group IIA secretory phospholipase A2 in PC12 cells: the newly synthesized enzyme is addressed to growing neurites.

Authors:  Vincenza Nardicchi; Monica Ferrini; Francesca Pilolli; Emanuela Biagioni Angeli; Emanuele Persichetti; Tommaso Beccari; Roberta Mannucci; Cataldo Arcuri; Rosario Donato; Robert V Dorman; Gianfrancesco Goracci
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

4.  Sustained activation of proton channels and NADPH oxidase in human eosinophils and murine granulocytes requires PKC but not cPLA2 alpha activity.

Authors:  Deri Morgan; Vladimir V Cherny; Alison Finnegan; James Bollinger; Michael H Gelb; Thomas E DeCoursey
Journal:  J Physiol       Date:  2006-12-21       Impact factor: 5.182

5.  Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction.

Authors:  David H Adler; Joy D Cogan; John A Phillips; Nathalie Schnetz-Boutaud; Ginger L Milne; Tina Iverson; Jeffrey A Stein; David A Brenner; Jason D Morrow; Olivier Boutaud; John A Oates
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

6.  The enteropathy of prostaglandin deficiency.

Authors:  David H Adler; John A Phillips; Joy D Cogan; Tina M Iverson; Nathalie Schnetz-Boutaud; Jeffrey A Stein; David A Brenner; Ginger L Milne; Jason D Morrow; Oliver Boutaud; John A Oates
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

7.  Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.

Authors:  Georgia Antonopoulou; Efrosini Barbayianni; Victoria Magrioti; Naomi Cotton; Daren Stephens; Violetta Constantinou-Kokotou; Edward A Dennis; George Kokotos
Journal:  Bioorg Med Chem       Date:  2008-11-01       Impact factor: 3.641

8.  Regulation and function of epithelial secreted phospholipase A2 group X in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William A Altemeier; Cara L Appel; Brian Johnson; Charles W Frevert; Kelly L Hudkins; James G Bollinger; Prescott G Woodruff; Dallas M Hyde; William R Henderson; Michael H Gelb
Journal:  Am J Respir Crit Care Med       Date:  2013-07-01       Impact factor: 21.405

9.  Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation.

Authors:  Bogeon Yun; HeeJung Lee; Moumita Ghosh; Benjamin F Cravatt; Ku-Lung Hsu; Joseph V Bonventre; Heather Ewing; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

10.  Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer.

Authors:  Manish I Patel; Jaskirat Singh; Marzieh Niknami; Caroline Kurek; Mu Yao; Sasa Lu; Fiona Maclean; Nicholas J C King; Michael H Gelb; Kieran F Scott; Pamela J Russell; John Boulas; Qihan Dong
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.